NCOA4 and nonpapillary renal cell carcinoma: Finally, a four-gene prognostic model was constructed to determine various prognoses of ccRCC patients, and the model implied that CD44, DPP4, NCOA4, and SLC7A11 may serve as potential molecular biomarkers of ccRCC.